CooperVision Adds SynergEyes to Expand Specialty Contact Lens Adoption in North America

Monday, November 7 2022 | 03 h 48 min | Agreements and Acquisitions, News, Press Release

Deepening its commitment to expand specialty contact lens adoption in North America and worldwide, CooperVision has added SynergEyes to its CooperVision Specialty EyeCare business unit. The Carlsbad, Calif.-based company is widely known for hybrid lens technologies and brands, which span the treatment of irregular cornea, presbyopia, and astigmatism.

This development broadens CooperVision’s already extensive range of products and services. The addition creates a complete portfolio for the treatment of keratoconus and irregular cornea in North America and beyond, plus substantial opportunities to advance care for other common ocular conditions.

“Eye care practitioners are searching for ways to differentiate themselves, with a growing number embracing specialty contact lenses for their clinical and business advantages. Combining these two specialty segment experts provides a full range of options which delivers a continuum of care for keratoconus,” said Juan Carlos Aragón, OD, President, CooperVision Specialty EyeCare.

Since the first generation of SynergEyes hybrid lenses came to market in 2005, the company has continued to improve the multifaceted technologies required for success. Its brands include Duette^®, UltraHealth^®, and SynergEyes^® iD Single Vision and Multifocal EDOF, as well as SynergEyes VS™ scleral lenses.

Over the next few years, manufacturing of SynergEyes products and materials will transition to CooperVision Specialty EyeCare’s recently opened production center in Gilbert, Ariz. GP Specialists, whom CooperVision acquired in 2021, has shared plans to move into that facility in 2023.

SynergEyes customers should continue to work with their current representatives. Terms of the transaction were not disclosed.

Click HERE for the full press release.